Oscar Health, Inc. (NYSE:OSCR - Get Free Report) has received an average rating of "Strong Sell" from the nine ratings firms that are presently covering the company, MarketBeat.com reports. Five equities research analysts have rated the stock with a sell recommendation and four have given a hold recommendation to the company. The average 1 year target price among brokerages that have issued ratings on the stock in the last year is $12.0714.
A number of research analysts have issued reports on the stock. Barclays decreased their target price on shares of Oscar Health from $17.00 to $11.00 and set an "underweight" rating on the stock in a research report on Wednesday, July 23rd. Raymond James Financial lowered shares of Oscar Health from an "outperform" rating to a "market perform" rating in a research report on Tuesday, June 24th. UBS Group restated a "sell" rating and set a $11.00 target price (down previously from $15.00) on shares of Oscar Health in a research report on Tuesday, July 15th. Piper Sandler decreased their target price on shares of Oscar Health from $14.00 to $13.00 and set a "neutral" rating on the stock in a research report on Thursday, August 14th. Finally, Wall Street Zen lowered shares of Oscar Health from a "hold" rating to a "sell" rating in a research report on Saturday, August 9th.
Get Our Latest Report on OSCR
Oscar Health Stock Up 8.9%
Oscar Health stock opened at $16.7920 on Monday. The stock has a market cap of $4.34 billion, a P/E ratio of -20.73 and a beta of 1.86. The company has a quick ratio of 0.86, a current ratio of 0.86 and a debt-to-equity ratio of 0.26. Oscar Health has a twelve month low of $11.20 and a twelve month high of $23.79. The company's 50-day moving average price is $16.12 and its two-hundred day moving average price is $14.80.
Oscar Health (NYSE:OSCR - Get Free Report) last announced its earnings results on Wednesday, August 6th. The company reported ($0.89) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.90) by $0.01. Oscar Health had a negative net margin of 1.50% and a negative return on equity of 13.78%. The firm had revenue of $2.86 billion for the quarter, compared to analyst estimates of $2.88 billion. During the same quarter in the prior year, the business posted $0.20 EPS. The business's revenue was up 29.0% compared to the same quarter last year. As a group, analysts expect that Oscar Health will post 0.69 EPS for the current year.
Institutional Trading of Oscar Health
Several large investors have recently made changes to their positions in OSCR. Deerfield Management Company L.P. Series C boosted its position in shares of Oscar Health by 50.7% during the 4th quarter. Deerfield Management Company L.P. Series C now owns 11,835,000 shares of the company's stock worth $159,062,000 after acquiring an additional 3,983,325 shares in the last quarter. Nuveen LLC acquired a new stake in shares of Oscar Health during the 1st quarter worth approximately $29,684,000. Thrive Capital Management LLC boosted its position in shares of Oscar Health by 33.4% during the 4th quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company's stock worth $85,258,000 after acquiring an additional 1,588,395 shares in the last quarter. Man Group plc boosted its position in shares of Oscar Health by 344.8% during the 4th quarter. Man Group plc now owns 1,813,216 shares of the company's stock worth $24,370,000 after acquiring an additional 1,405,554 shares in the last quarter. Finally, Jump Financial LLC boosted its position in shares of Oscar Health by 798.3% during the 2nd quarter. Jump Financial LLC now owns 1,441,506 shares of the company's stock worth $30,906,000 after acquiring an additional 1,281,032 shares in the last quarter. Institutional investors and hedge funds own 75.70% of the company's stock.
Oscar Health Company Profile
(
Get Free Report)
Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Oscar Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.
While Oscar Health currently has a Strong Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.